About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Illinois | 390 Studies

Clinical Trials Colorectal CancerIllinois

Colorectal Cancer Clinical Trials in Illinois

Find 390 clinical trials for colorectal cancer near Illinois. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 390 trials

CompletedEfficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)This is an efficacy and safety study of olaparib alone or in combination with bevacizumab being compared to bevacizumab with a fluoropyrimidine in participants with unresectable…NCT04456699·Burbank, California and 128 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingIntegrated Cancer Repository for Cancer ResearchThe iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal…NCT02012699·Greenwood Village, Colorado and 41 others

CompletedShark Cartilage in Treating Patients With Advanced Colorectal or Breast CancerRATIONALE: Shark cartilage extract may help shrink or slow the growth of colorectal cancer or breast cancer cells.NCT00026117·Scottsdale, Arizona and 15 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

CompletedS9923 R115777 in Treating Patients With Advanced Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005833·Los Angeles, California and 11 others

CompletedCollection of Patient-Reported Symptoms and Performance Status Via the InternetThis pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and…NCT00417040·Castro Valley, California and 94 others

Enrolling by invitationThe Implementation of Genetic Risk for Colorectal Cancer ScreeningThe goal of this study is to investigate genetic risk for colorectal cancer utilizing polygenic risk scores (PRS) for adults over 45 who have not received their first colonoscopy.NCT07621757·Evanston, Illinois

Active not recruitingEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsThis trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects…NCT03485209·Encinitas, California and 174 others

CompletedOxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00026299·Chicago, Illinois and 11 others

CompletedA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersThis is a first-in-human, Phase 1, multicenter, open-label, dose-escalation study to establish the maximum-tolerated dose (MTD) or recommended dosage (RD) of ZW49, the…NCT03821233·Duarte, California and 15 others

CompletedImproving Rates of Colorectal Cancer Screening Among Never Screened PatientsThe United States Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening using fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy…NCT01742169·Chicago, Illinois

RecruitingNeoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3This phase II trial tests how well giving botensilimab and balstilimab prior or to surgery (neoadjuvent) works for the treatment of colorectal cancer that may have spread from…NCT07595874·Goodyear, Arizona and 10 others

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

SuspendedCANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2The purpose of this study is to test the CANscript™ sensitivity assay, which is a new and different assay developed to test the sensitivity of different cancer types to physician…NCT03253575·Gilbert, Arizona and 29 others

RecruitingTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialThis phase III trial compares hepatic arterial infusion (HAI) (pump chemotherapy) in addition to standard of care chemotherapy versus standard of care chemotherapy alone in…NCT05863195·Birmingham, Alabama and 61 others

Active not recruitingColonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)Colorectal cancer (CRC) is currently the second most common cause of cancer death in the United States, and one of the most preventable cancers.NCT01239082·Phoenix, Arizona and 45 others

WithdrawnIrofulven in Treating Patients With Metastatic or Recurrent Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003786·Chicago, Illinois and 8 others

TerminatedTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):This was a randomized, double-blind, placebo-controlled, global, multicenter, Phase 3 trial evaluating the impact of trilaciclib on myelopreservation and anti-tumor efficacy when…NCT04607668·Tucson, Arizona and 81 others

TerminatedSafety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.The purpose of this study is to assess the Safety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic…NCT00065117·Los Angeles, California and 9 others

CompletedA Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerThis study will assess the safety of RAD001 when given together with cetuximab and irinotecanNCT00478634·Fayetteville, Arkansas and 15 others

PreviousPage 7 of 20Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma